Apogee Therapeutics (APGE) Other Non Operating Income (2022 - 2026)

Apogee Therapeutics (APGE) has 5 years of Other Non Operating Income data on file, last reported at $8.7 million in Q1 2026.

• On a quarterly basis, Other Non Operating Income rose 11.48% year-over-year to $8.7 million in Q1 2026; TTM through Mar 2026 was $30.9 million, a 15.25% decrease from a year earlier, with the FY2025 full-year figure at $30.0 million, down 13.56% from the prior year.
• Other Non Operating Income for Q1 2026 stood at $8.7 million, roughly flat from $8.7 million in the prior quarter.
• Over the last five years, Other Non Operating Income for APGE reached as high as $10.3 million in Q2 2024 and fell as low as -$9.2 million in Q3 2022.
• Historically, Other Non Operating Income has averaged $5.2 million across 5 years, with a median of $6.7 million in 2025.
• Across the five-year window, Other Non Operating Income soared 5791.3% in 2023 and slumped 34.65% in 2025, its largest moves.
• Year by year, Other Non Operating Income stood at $92000.0 in 2022, then surged by 5791.3% to $5.4 million in 2023, then surged by 60.17% to $8.7 million in 2024, then rose by 0.58% to $8.7 million in 2025, then gained by 0.1% to $8.7 million in 2026.
• Per Business Quant data, the three most recent Other Non Operating Income figures were $8.7 million in Q1 2026, $8.7 million in Q4 2025, and $6.3 million in Q3 2025.